Europe biotechnology research

Chemical companies also perform little research outside their home country. The overall average of overseas invented patents is 11.6%. European companies locate 86.0% of their researeh activity in chemicals in Europe. In biotechnology, this share drops to 80.2% suggesting that European companies locate biotechnology research abroad more than in the other chemical sectors and much more than the other countries do. The share of bioteehnology patents invented abroad by European companies is 19.8% (16.6% invented in the US vs. 5.1% of American biotechnological patents invented in Europe). 

Data-Star. This is Europe s leading on-line database service (39) and covers worldwide business news, financial information, market research, trade statistics, business analysis, healthcare / pharmaceuticals, chemicals / petrochemicals, chemical industry, biomedicine /life science, biotechnology, and technology, with an emphasis on Europe. It was originally formed as a joint venture among BRS, Predicasts, and Radio Suisse (the Swiss telecommunications company) (37). Data-Star offers access to about 300 bibliographic, abstract, directory, and fuU-text on-line databases, of which approximately 150 are also available on Dialog (40). 

Programme (FP6). The FP6 is the framework for the EU activity in the field of science, research, and innovation. The main objective of the FP6 is to contribute to the creation of the European Research Area (ERA) by improving integration and coordination of research in Europe. One of seven priority thematic areas is Life Science, Genomics and Biotechnology for Health. 

Profile The company provides scientific information products and services to the fine-chemical, pharmaceutical, agrochemical, biotechnology, and academic research communities. Synopsys operates worldwide, with offices and distributors in Europe, the United States, and Japan. It specializes in chemical reaction databases that deliver added-value information and refined data. 

Ethical considerations across the whole spectrum of biotechnology are being discussed in Europe, dealing with environmental applications, food production, human health, animal welfare, research, industry, the north/south divide, biodiversity, public perceptions and media, and stress the consideration of the interest of future generations. 

---